FIGURE

Fig. 2

ID

ZDB-FIG-250724-39

Publication

Herdt et al., 2025 - In vivo measurement of an Apelin gradient with a genetically encoded APLNR conformation biosensor

Other Figures

All Figure Page

Back to All Figure Page

Fig. 2

Pharmacological characterization of the APLNR-cpGFP biosensors.

Stimulation with Apelin and Apela (arrow indicates timepoint of ligand addition) led to a significant increase of APLNR(F233)-cpGFP (a, c) and APLNR(K235)-cpGFP (b, d) biosensor fluorescent intensity. The APLNR antagonist ML-221 significantly diminished the Apelin-induced fluorescent response of APLNR(F233)-cpGFP (e) and APLNR(K235)-cpGFP (f). Data are presented as mean values ± SEM from three independent experiments conducted in stable APLNR-cpGFP expressing HEK293T cells. cpGFP circularly permuted GFP, HEK293T human embryonic kidney 293T. Source data are provided as a Source Data file.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Nat. Commun.